Investigation of Efficacy and Safety of Electrical Signal Therapy Provided by Dr Biolyse® Device in COVID-19 Disease

NACompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

September 1, 2022

Primary Completion Date

May 16, 2023

Study Completion Date

April 15, 2024

Conditions
COVID-19 PneumoniaVirus DiseasesCOVID-19
Interventions
DEVICE

Signal Therapy provided by Dr.Biolyse device

Before the application, the area where the electrodes will be cleaned with appropriate solutions. In addition, 500-1000 ml of isotonic serum will be supplemented according to your weight, just before the first electrical signal application during the day. Electrical signal will be applied to the lung and upper leg area for 90 minutes in the morning, noon, and evening on the first 3 days, 60 minutes in the morning and evening on the 4th and 5th days, to the lung and upper leg area. During your first hospitalization, blood will be drawn from you daily for 5 days and evaluated in terms of various biochemical parameters and detailed molecular analyzes.

OTHER

Liquid Support Treatment

The control group will only receive fluid therapy and will be monitored with the same blood parameters throughout the hospitalization.

Trial Locations (1)

Unknown

Bezmialem Vakif University Dragos Hospital, Istanbul

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AVB Biotechnology

INDUSTRY